Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes

NCT05769335
not_yet_recruitingnot_applicable

Exploring IHG Training in CR

NCT06454487
completed

Ultra-low Dose Chest Computed Tomography: a Rule-out Tool for Community-acquired Pneumonia

NCT04541160

Clinical Trials (3)

Showing 3 of 3 trials
NCT05769335Not Applicable

Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes

Completed
NCT06454487Not Applicable

Exploring IHG Training in CR

Not Yet Recruiting
NCT04541160

Ultra-low Dose Chest Computed Tomography: a Rule-out Tool for Community-acquired Pneumonia

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3